Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Change of Control: Why Getting it Right Matters Even More

Mar 01 2008

Related Content

Genzyme/Isis: Has ENHANCE Dulled Mipomersen's Prospects?

Feb 01 2008

Dynogen Tries the SPAC Alternative

Mar 01 2008

Infinity Reverse Merges Into Discovery Partners

May 01 2006

Related Companies

Eisai Co., Ltd.

MGI Pharma

Bristol Myers Squibb Company

Wyeth

Biogen, Inc.

Elan Corporation

Genentech, Inc.

Johnson & Johnson

Trubion Pharmaceuticals

Abbott

Infinity Pharmaceuticals, Inc.

MedImmune LLC

AstraZeneca PLC

Ionis Pharmaceuticals, Inc.

Additional Topics

Strategy Business Strategies Legal Issues BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window